Banner for leaf pages 2


Also known as Requip

Ropinirole (INN; trade names Requip, Ronirol, Adartrel) is a dopamine agonist of the non-ergoline class of medications. It is manufactured by GlaxoSmithKline (GSK), Cipla, Dr. Reddy's Laboratories and Sun Pharmaceutical. It is used in the treatment of Parkinson's disease and Restless Legs Syndrome (RLS). Ropinirole is one of three medications approved by the FDA to treat Restless Legs Syndrome (RLS), the other two being pramipexole (Mirapex) and gabapentin enacarbil (Horizant). The discovery of the drug's utility in (RLS) has been used as a successful example of drug repurposing.

Source: Wikipedia

Estimated Total Cost: $40.54 for an average of 28 days supply

What is it prescribed for?

Patients are most commonly prescribed ropinirole to treat parkinson disease, restless leg syndrome, abnormal involuntary movements, and obstructive sleep apnea (osa).

Ajax-loader Loading...